EXOZ EXOZ
Company Profile ↓Company Overview
EXOZ (EXOZ) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -45.27% |
| 6 Months: | -51.64% |
| 3 Months: | -44.98% |
| 1 Month: | -28.37% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 67.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | - | - | -391.85K | -1.01M | -1.33M | -1.61M | -1.95M | -2.55M | -2.52M | -2.39M |
| Net Income | -241.15K | -178.08K | -520.60K | -1.01M | -1.36M | -1.66M | -1.86M | -2.36M | -2.29M | -2.37M |
| Diluted EPS | - | - | -0.08 | -0.16 | -0.22 | -0.27 | -0.22 | -0.28 | -0.27 | -0.28 |
| R&D Expense | - | - | 27.94K | 277.58K | 237.40K | 723.49K | 575.02K | 802.99K | 1.22M | 1.12M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 70.07K | - | - |
| Operating Income | -1.80M | -5.93M | -9.72M |
| Net Income | -2.04M | -5.86M | -9.16M |
| Diluted EPS | -0.33 | -0.89 | -1.09 |
| R&D Expense | 527.48K | 1.87M | 3.71M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | 3.56M | 13.03M | 5.97M |
| Total Equity | 1.37M | -384.32K | 10.42M | 3.40M |
| Cash & Equivalents | - | 66.53K | 9.72M | 3.04M |
| Total Liabilities | - | 3.94M | 2.61M | 2.57M |
| Current Liabilities | - | 2.42M | 1.33M | 1.57M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -1.18M | -8.51M | -6.50M |
| Investing Cash Flow | -311.17K | -359.22K | -150.22K |
| Financing Cash Flow | 1.00M | 18.52M | -27.71K |
| Capital Expenditure | -288.71K | -396.45K | -169.92K |
| Free Cash Flow | -1.47M | -8.90M | -6.67M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | -2,563.5% | - | - |
| Net Margin % | -2,909.1% | - | - |
| ROE % | 530.4% | -56.2% | -269.6% |
| ROCE % | -157.1% | -50.7% | -220.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EXOZ
eXoZymes and Berkeley Lab Develop AI-Powered Digital Twins - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPaG5HT05mcWlpMUJxUGUtVi1mYTZUTHFTdldWR04xU3o0dEdTWnhqTE1IYXN3WDhsRWNId3NpZjlmek9BdzF0b293OWp3M2todU9IYTMzdFh3WjF3Wk1FQzNoS0lRRmlMVnhSamhoY19ncVRudWNONTE1YV9kVmxNYkdxRVByaUIyMlZ2Nk…
eXoZymes Inc. Revenue Breakdown – NASDAQ:EXOZ - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9LQlk3OG9jY0ZuZWpmWmFxRnRSd2NndDdMNUMxUW5fUEh0NUxZZ2hPLWVtRmRVTnd3NmRUcnEtTlNRNDA2cHlEWnpybmlBUXBneS03QTVMeWltMGZIaHZyMnlSd0dISDJkMHgzaGV2aWZRcWxyRmFv?oc=5" target="_blank">eXoZyme…
Precision Trading with EXOZ Company (EXOZ) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPc2ZWUjIxZG9qNmdaZ0tvalFjYnZjUnY1UW9Bc3hHQ2FKZEVJdkU1WHRKQW9fZlhkT3A4VGlUeFQxdHA4djR1MGpKLUktcUhybk1hb1hQbTVuV01XTkN4RkZmZ1g4THhEQjN4V0l1THFMcnA1akxLRVVvX2t3RjRIdXlRYzROdFNGTjc3SD…
eXoZymes Inc (EXOZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1SVVo5QWI2RE9tdUJXTEdHYXpPRVZRT1h5ZmtYR0JYR2Z0UlJYNktrX2ZxM0JPSEJUMndZSWljeUppVDBPdGVWQ2hyay1VT1BzRGxvNC1qRE1CZ0dNMENEWUQwMVQ?oc=5" target="_blank">eXoZymes Inc (EXOZ) Revenue Brea…
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - newswire.com
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNOTR3Y0NOZWNhX3RxMlBZZF9sd191V2lyZ3A0UFNDdHU5UHhLd182OENXV282cE1Rdkh5bTU3WTI0U2pSWUhNOVVnZVlrc2Q3TjI1c29qemprem9rNEwwMF9VUHJXYThvU3Q5N3ppN1pSVUYyTGY3Vm1ta3RpbUpxLTZUaFlXOGwxVHFJQ1…
eXoZymes, Inc. (NASDAQ: EXOZ) Share Price, EXOZ Stock News, EXOZ Share Price & Updates - Kalkine
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1PWXZHSE1HNTl5dXl3dkJmTy1ibTRlb3R3bThfcFFxdFhiU0E2eDlLNi0tQ2FpNFRuV3QxNDlBaUJJR2lINFNHS001aXcwMUoxdWJoVkNR?oc=5" target="_blank">eXoZymes, Inc. (NASDAQ: EXOZ) Share Price, EXOZ Sto…
EXOZ — Frequently Asked Questions
What is the current share price of EXOZ?
As of 2026-08-05 17:25 PDT, EXOZ trades at $5.44 on NASDAQ/NYSE. Its 52-week range is $4.40 to $16.50.
What is the P/E ratio of EXOZ?
EXOZ trades at a trailing price-to-earnings (P/E) ratio of -4.99.
Is EXOZ a good stock to buy?
This page provides a data-driven analysis of EXOZ, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.